Order Article Reprints

Wang C-Y, Dai H-R, Tan Y-P, Yang D-H, Niu X-M, Han L, Wang W, Ma L-L, Julku A, Jiao Z. Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals. 2024; 17(2):238. https://doi.org/10.3390/ph17020238

Wang, Chen-Yu, Hao-Ran Dai, Yu-Ping Tan, Di-Hong Yang, Xiao-Min Niu, Lu Han, Wen Wang, Ling-Ling Ma, Aleksi Julku, and Zheng Jiao. 2024. "Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer" Pharmaceuticals 17, no. 2: 238. https://doi.org/10.3390/ph17020238

Wang, C.-Y., Dai, H.-R., Tan, Y.-P., Yang, D.-H., Niu, X.-M., Han, L., Wang, W., Ma, L.-L., Julku, A., & Jiao, Z. (2024). Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals, 17(2), 238. https://doi.org/10.3390/ph17020238